Elevated Serum α-Fetoprotein is Associated with Abbreviated Survival for Patients with Fibrolamellar Hepatocellular Carcinoma Who Undergo a Curative Resection.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
    • Publication Information:
      Publication: 2005- : New York, NY : Springer
      Original Publication: New York, NY : Raven Press, c1994-
    • Subject Terms:
      Biomarkers, Tumor/*blood ; Carcinoma, Hepatocellular/*mortality ; Hepatectomy/*mortality ; alpha-Fetoproteins/*analysis; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular/blood ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/surgery ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Survival Rate
    • Abstract:
      Background: Fibrolamellar hepatocellular carcinoma (FLC) is a rare variant of hepatocellular carcinoma (HCC), with most clinical data stemming from single-institution series. The variability in the literature lends support for analysis using a large national dataset. In doing so, we sought to (1) define the characteristics and outcomes of patients with FLC; (2) determine factors associated with survival in patients undergoing resection; and (3) compare the overall survival (OS) of patients with FLC with a matched group of patients with HCC.
      Methods: The National Cancer Database was queried for patients with FLC, and their clinicopathologic features were recorded. Univariate and multivariate analyses were performed to delineate factors associated with survival.
      Results: Between 2004 and 2015, 496 patients were diagnosed with FLC, 229 of whom underwent a curative resection. The median OS for patients with FLC undergoing curative resection was 78.5 months. Factors associated with abbreviated OS in this surgical cohort include multiple tumors [hazard ratio (HR) 3.15, p = 0.025], positive regional lymph nodes (HR 2.83, p = 0.023), and elevated serum α-fetoprotein (AFP; HR 2.81, p = 0.034). When the OS of patients with FLC was compared with a matched group of patients with HCC, no difference was detected (p = 0.748); however, patients with FLC and elevated AFP had abbreviated OS compared with patients with HCC and elevated AFP (43 vs. 82 months, p ≤ 0.001).
      Conclusions: Elevations in serum AFP occur more frequently than previously documented for patients with FLC and are associated with abbreviated OS. AFP levels may help guide the decision for operative intervention in patients with FLC.
    • References:
      J Surg Oncol. 2017 Dec;116(7):831-840. (PMID: 28743160)
      J Hepatocell Carcinoma. 2015 Oct 09;2:151-7. (PMID: 27508204)
      J Am Coll Surg. 2012 Dec;215(6):820-30. (PMID: 22981432)
      J Gastrointest Surg. 2016 Oct;20(10):1725-31. (PMID: 27456016)
      J Am Coll Surg. 2014 Feb;218(2):196-205. (PMID: 24315886)
      Ann Surg Oncol. 2014 Mar;21(3):986-94. (PMID: 24232510)
      AMA J Dis Child. 1956 Feb;91(2):168-86. (PMID: 13282629)
      J Pediatr Surg. 2015 Jan;50(1):153-6. (PMID: 25598114)
      Oncology. 2013;85(4):197-203. (PMID: 24051705)
      Gastrointest Cancer Res. 2013 Jan;6(1):3-9. (PMID: 23505572)
      Hepatology. 2004 Mar;39(3):798-803. (PMID: 14999699)
      Cancer. 1980 Jul 15;46(2):372-9. (PMID: 6248194)
      J Gastrointest Oncol. 2019 Jun;10(3):554-561. (PMID: 31183207)
      J Surg Oncol. 2014 Sep;110(4):412-5. (PMID: 24844420)
    • Grant Information:
      ZIA BC011861 United States ImNIH Intramural NIH HHS
    • Accession Number:
      0 (Biomarkers, Tumor)
      0 (alpha-Fetoproteins)
    • Subject Terms:
      Fibrolamellar hepatocellular carcinoma
    • Publication Date:
      Date Created: 20200112 Date Completed: 20210202 Latest Revision: 20210923
    • Publication Date:
      20231215
    • Accession Number:
      PMC8456707
    • Accession Number:
      10.1245/s10434-019-08178-x
    • Accession Number:
      31925595